IL126480A0 - Carbapenem antibacterial compounds compositions containing such compounds and methods of treatment - Google Patents

Carbapenem antibacterial compounds compositions containing such compounds and methods of treatment

Info

Publication number
IL126480A0
IL126480A0 IL12648097A IL12648097A IL126480A0 IL 126480 A0 IL126480 A0 IL 126480A0 IL 12648097 A IL12648097 A IL 12648097A IL 12648097 A IL12648097 A IL 12648097A IL 126480 A0 IL126480 A0 IL 126480A0
Authority
IL
Israel
Prior art keywords
compounds
treatment
methods
compositions containing
carbapenem antibacterial
Prior art date
Application number
IL12648097A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9609741.5A external-priority patent/GB9609741D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL126480A0 publication Critical patent/IL126480A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL12648097A 1996-04-24 1997-04-21 Carbapenem antibacterial compounds compositions containing such compounds and methods of treatment IL126480A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1618496P 1996-04-24 1996-04-24
GBGB9609741.5A GB9609741D0 (en) 1996-05-10 1996-05-10 Carbapenem antibacterial compounds compositions containing such componds and methods of treatment
PCT/US1997/006626 WO1997040048A1 (en) 1996-04-24 1997-04-21 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Publications (1)

Publication Number Publication Date
IL126480A0 true IL126480A0 (en) 1999-08-17

Family

ID=26309297

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12648097A IL126480A0 (en) 1996-04-24 1997-04-21 Carbapenem antibacterial compounds compositions containing such compounds and methods of treatment

Country Status (31)

Country Link
EP (1) EP0906313B1 (de)
JP (1) JP3176068B2 (de)
KR (1) KR20000010599A (de)
CN (1) CN1074767C (de)
AR (1) AR006810A1 (de)
AT (1) ATE260915T1 (de)
AU (1) AU707459B2 (de)
BG (1) BG102949A (de)
BR (1) BR9708864A (de)
CA (1) CA2252402C (de)
CO (1) CO4990968A1 (de)
CZ (1) CZ340798A3 (de)
DE (1) DE69727931T2 (de)
EA (1) EA001296B1 (de)
EE (1) EE03689B1 (de)
ES (1) ES2216142T3 (de)
HK (1) HK1021186A1 (de)
HR (1) HRP970213A2 (de)
HU (1) HUP9901778A3 (de)
ID (1) ID16662A (de)
IL (1) IL126480A0 (de)
IS (1) IS4861A (de)
NO (1) NO984949L (de)
NZ (1) NZ332183A (de)
PE (1) PE64298A1 (de)
PL (1) PL186881B1 (de)
SK (1) SK283550B6 (de)
TR (1) TR199802140T2 (de)
TW (1) TW539677B (de)
WO (1) WO1997040048A1 (de)
YU (1) YU46298A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163522B1 (en) 1994-03-02 2007-01-16 Scimed Life Systems, Inc. Block copolymer elastomer catheter balloons
US6406457B1 (en) 1994-03-02 2002-06-18 Scimed Life Systems, Inc. Block copolymer elastomer catheter balloons
EP0981522A1 (de) * 1997-05-13 2000-03-01 Merck & Co., Inc. Verfahren zur herstellung von carbapenem zwischenprodukten
US5908936A (en) * 1997-05-13 1999-06-01 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
AU752313B2 (en) * 1997-10-23 2002-09-12 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6140318A (en) * 1997-10-23 2000-10-31 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
JP2002509856A (ja) * 1997-10-23 2002-04-02 メルク エンド カムパニー インコーポレーテッド カルバペネム系抗菌化合物、組成物および治療方法
US6271222B1 (en) * 1998-05-28 2001-08-07 Merck & Co., Inc. Penem antibacterial compounds, compositions and methods of treatment
ATE263766T1 (de) * 1998-06-17 2004-04-15 Merck & Co Inc Verfahren zur synthese von carbapenem- zwischenprodukten
WO1999066927A1 (en) * 1998-06-25 1999-12-29 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
JP2002518497A (ja) * 1998-06-25 2002-06-25 メルク エンド カムパニー インコーポレーテッド （複素環）メチル置換カルバペネムカルバペネム抗細菌物質
US7672747B2 (en) 2000-03-30 2010-03-02 Lam Research Corporation Recipe-and-component control module and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
US5451579A (en) * 1994-02-15 1995-09-19 Merck & Co., Inc. 1-β-methyl-carbapenem, compositions containing same and methods of use

Also Published As

Publication number Publication date
CN1074767C (zh) 2001-11-14
DE69727931T2 (de) 2005-04-14
TW539677B (en) 2003-07-01
CZ340798A3 (cs) 1999-03-17
EP0906313B1 (de) 2004-03-03
EA199800949A1 (ru) 1999-04-29
HUP9901778A2 (hu) 1999-09-28
CA2252402C (en) 2002-12-24
NO984949L (no) 1998-12-21
PL329376A1 (en) 1999-03-29
PL186881B1 (pl) 2004-03-31
BR9708864A (pt) 1999-08-03
EP0906313A1 (de) 1999-04-07
CN1222912A (zh) 1999-07-14
EE9800355A (et) 1999-04-15
ATE260915T1 (de) 2004-03-15
CO4990968A1 (es) 2000-12-26
HRP970213A2 (en) 1998-06-30
AU707459B2 (en) 1999-07-08
HK1021186A1 (en) 2000-06-02
KR20000010599A (ko) 2000-02-15
PE64298A1 (es) 1998-10-30
WO1997040048A1 (en) 1997-10-30
SK283550B6 (sk) 2003-09-11
ID16662A (id) 1997-10-30
YU46298A (sh) 2000-03-21
IS4861A (is) 1998-10-06
DE69727931D1 (de) 2004-04-08
JP3176068B2 (ja) 2001-06-11
AR006810A1 (es) 1999-09-29
NZ332183A (en) 2000-05-26
AU2462997A (en) 1997-11-12
EA001296B1 (ru) 2000-12-25
CA2252402A1 (en) 1997-10-30
ES2216142T3 (es) 2004-10-16
HUP9901778A3 (en) 2000-06-28
NO984949D0 (no) 1998-10-23
SK145498A3 (en) 1999-10-08
JPH11508279A (ja) 1999-07-21
TR199802140T2 (xx) 1999-01-18
BG102949A (bg) 1999-10-29
EE03689B1 (et) 2002-04-15

Similar Documents

Publication Publication Date Title
ZA973487B (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment.
IL126480A0 (en) Carbapenem antibacterial compounds compositions containing such compounds and methods of treatment
AU7961498A (en) 9a-azalides, compositions containing such compounds and methods of treatment
AU7986098A (en) 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
EP1021445A4 (de) Antibakterielle carbapenem-verbindungen, zubereitungen die solche verbindungen enthalten und behandlungsverfahren
EP1084105A4 (de) Antibakterizide carbopenemverbindungen, zusammensetzungen mit ihnen und herstellungsverfahren
EP0977567A4 (de) Antibakterielle carbapenem-verbindungen, die enthaltende zusammensetzungen und behandlungsmethoden
GB9624277D0 (en) Carbapenem antibacterial compounds compositions containing such compounds and methods of treatment
GB9814269D0 (en) 9a-Aza-3-ketolides, compositions containing such compounds and methods of treatment
EP1027353A4 (de) Antibakerielle carbapenem-verbindungen, zusammensetzungen, die diese enthalten und behandlungsmethoden
GB9815806D0 (en) Carbapenem antibacterial compounds compositions containing such compounds and methods of treatment
GB9807942D0 (en) Carbapenem antibacterial compounds compositions containing such compounds and methods of treatment
GB9609741D0 (en) Carbapenem antibacterial compounds compositions containing such componds and methods of treatment
EP1027352A4 (de) Antibakterielle carbapenem-verbindungen, zusammensetzungen und behandlungsmethoden
EP1032384A4 (de) Antibakterielle carbapenem-verbindungen, zusammensetzungen und verfahren zur behandlung
GB9317943D0 (en) Treatment of laminitis
AU3215395A (en) Carbapenem compounds, compositions and methods of treatment
EP1089729A4 (de) Antibakterielle carbapenem verbindungen, zusammenstellungen die diese enthalten und behandlungsmethoden
EP1089730A4 (de) Antibakterielle carbapenemverbindungen , zusammenstellungen die diese enthalten und behandlungsmethoden
GB9701605D0 (en) Carbapenham antibacterial compounds compositions containing such compounds and methods of treatment
GB9810174D0 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
GB9806433D0 (en) Carbapenem antibacterial compounds,compositions containing such compounds and methods of treatment
GB9806431D0 (en) Carbapenem antibacterial compounds,compositions containing such compounds and methods of treatment
GB2301353B (en) Treatment of undesirable halogenated organic compounds
ZA93491B (en) Treatment of psychoses